14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KROS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Keros Therapeutics Inc. stock downgraded after the last trading session.
(Updated on May 06, 2024)

Buy or Hold candidate since May 03, 2024 Loss -0.51% PDF

The Keros Therapeutics Inc. stock price fell by -0.512% on the last day (Monday, 6th May 2024) from $60.57 to $60.26. During the last trading day the stock fluctuated 3.15% from a day low at $59.91 to a day high of $61.80. The price has been going up and down for this period, and there has been a 8.03% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -318 thousand shares and in total, 249 thousand shares were bought and sold for approximately $14.98 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.78% during the next 3 months and, with a 90% probability hold a price between $51.22 and $64.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KROS Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 11.20%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Keros Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $61.22. On a fall, the stock will find some support from the short-term average at $58.36. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Keros Therapeutics Inc. stock

Keros Therapeutics Inc. finds support from accumulated volume at $57.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.89 between high and low, or 3.15%. For the last week, the stock has had daily average volatility of 5.32%.

Our recommended stop-loss: $57.91 (-3.90%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (KROS) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Keros Therapeutics Inc. to open at $60.66, and during the day (based on 14 day Average True Range), to move between $57.10 and $63.42, which gives a possible trading interval of +/-$3.16 (+/-5.24%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $60.57 (0.51%) than the support at $57.72 (4.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Keros Therapeutics Inc. stock A Buy?

Keros Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.429 Hold/Accumulate Downgraded

Predicted Opening Price for Keros Therapeutics Inc. of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$60.66 ( 0.658%) $60.26

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KROS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 62.55 3.79 %
R2 61.82 2.60 %
R1 61.38 1.86 %
Current price: 60.26
Support S1 59.93 -0.540 %
S2 59.49 -1.28 %
S3 58.77 -2.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 67.35 11.77 %
R2 64.66 7.30 %
R1 60.57 0.514 %
Current price 60.26
Support S1 57.72 -4.22%
S2 57.35 -4.83%
S3 55.19 -8.41%

FAQ

What is the symbol for Keros Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Keros Therapeutics Inc. is KROS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.

What's the current price of Keros Therapeutics Inc. Stock?
As of the end of day on the May 06, 2024, the price of an Keros Therapeutics Inc. (KROS) share was $60.26.

What is the 52-week high and low for Keros Therapeutics Inc. Stock?
The 52-week high for Keros Therapeutics Inc. Stock is $95.57 and the 52-week low is $69.42.

What is the market capitalization of Keros Therapeutics Inc. Stock?
As of the May 06, 2024, the market capitalization of Keros Therapeutics Inc. is 2.168B.

When is the next earnings date for Keros Therapeutics Inc.?
The upcoming earnings date for Keros Therapeutics Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Keros Therapeutics Inc.

Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat... KROS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT